In this paper, we construct delayed HIV dynamics models with impairment of B-cell functions. Two forms of the incidence rate have been considered, bilinear and general. Three types of infected cells and five-time delays have been incorporated into the models. The well-posedness of the models is justified. The models admit two equilibria, which are determined by the basic reproduction number R 0 . The global stability of each equilibrium is proven by utilizing the Lyapunov function and LaSalle's invariance principle. Numerical simulations illustrate the theoretical results.
Introduction
Modeling the HIV dynamics has received considerable attention from mathematicians during the recent decades. A vast of mathematical models focused on exploring the relation between three main compartments, uninfected CD4 + T cells (U), infected cells producing viruses (I), and HIV particles (P). The first HIV dynamics model was proposed by Nowak and Bangham [45] as:
(1.1)
2)
P(t) = βM 1 I(t) − ξP(t).
(1.
3)
The production and death rate constants of compartments (U, I, P) are give by (ρ, ω, κ) and (γ, β, ξ), respectively. The term ωU(t)P(t) represents the incidence rate of infection, where ω is a positive constant. During the recent decades, much more modifications on the basic HIV dynamics model have been introduced (see e.g. [2-6, 8-30, 46, 47, 52, 54] ). Time delay between the initial virus contacts an uninfected cell and the production of new active viruses plays an important role in virus dynamics modeling. Time delay has been incorporated into the virus dynamics models in several works (see e.g. [6, 13, 14, 32, 35, 36, 38, 39, 44, 48] ). Mathematical models which include time delays are more accurate representations of biology when compared to the models without considering time delays. One of the most important extensions to model (1.1)-(1.3) is to incorporate the population of the B cells. The function of B cells is to produce antibodies which bind to virus particles and mark it as a foreign structure for elimination by other cells of the immune system [46] . The antibodies can neutralize viruses and protect the body from infection [40] . The basic virus dynamics model with B cell immune response has been presented by Murase et al. [43] . Wang and Zou [53] have proposed the following model which takes under consideration the time lag between the virus contacts an uninfected cell and the production of new mature viruses.U (t) = ρ − γU(t) − ωU(t)P(t), I(t) = ωU(t − τ 1 )P(t − τ 1 ) − βI(t),
where C(t) is the concentration of B cells. The term ρP(t)C(t) represents the neutralization rate of HIV particles. Parameters ε and µ are the proliferation and natural death rate constants of B cells, respectively. Parameter τ 1 represents the time between an HIV contacts an uninfected CD4 + T cell and the cell becomes infected. The immature virus needs time τ 2 to be mature. Many delayed viral infection models are developed with B cell immune response (see e.g. [19, 37, 42, 50, 51] ). Nowak and May [46] have assumed a linear term for immune stimulation: B cell abundance increases in response to free HIV particles at rate εP(t) and this leads toĊ(t) = εP(t) − µC(t).
On the other hand, there are some factors affect the B-cell function and cause the impairment of the B cells [1, 4, 7] . These factors include malnutrition, tumors, cytotoxic drugs, irradiation, aging, trauma, some diseases, e.g. diabetes, and immunosuppression by microbes, e.g., malaria, measles virus but especially HIV [40] . However, all previous delayed HIV models that constructed with B cell immune response ignoring the B-cell impairment. Miao et al. [41] have proposed a virus dynamics model with humoral impairment, but they did not studied the global stability analysis of the model.
The objective of the present paper is to propose and analyze two delayed HIV dynamics models taking into account the impairment of B cell functions. The infected cells are supposed to divided into three classes, latently infected, short lived productively infected, and long lived productively infected. The linear immune response is considered. In the second model, the incidence rate is given by a general nonlinear function. The nonnegativity and boundedness of the solutions are proven. The global stability of all equilibria of the models are established by constructing Lyapunov functions.
Delayed HIV infection model with B-cell impairment
The first suggested delayed HIV infection model with B-cell impairment is given by:
(2.1)
2)
I(t) = e −θ 2 τ 2 ω 2 U(t − τ 2 )P(t − τ 2 ) + νL(t) − βI(t), where L(t), I(t), and O(t) represent, respectively, the concentration of the latently infected cells, short lived productively infected cells, and long lived productively infected cells at time t. The term (ω 1 + ω 2 + ω 3 )U(t)P(t), represents the incidence rate. Latently infected cells die with rate ζL(t) and they are transmitted to short lived productively infected cells with rate νL(t). Parameters M 1 and M 2 are the average number of HIV particles generated in the lifetime of the short lived productively infected cells and long lived productively infected cells, respectively. Parameter Λ is the natural death rate constant of the long lived productively infected cells. The B cell impairment rate is given by ϑP(t)C(t). All previous described parameters are positive constants. Parameters τ 1 , τ 2 and τ 3 represent the times between HIV contacts an uninfected CD4 + T cell and the cell becomes latently infected, short lived productively infected and long lived productively infected, respectively. The factor e −θ k τ k , k = 1, 2, 3 represents the damage of CD4 + T cells during the interval [t − τ k , t]. The parameters τ 4 and τ 5 represent the time necessary for producing new mature HIV particles from the short lived productively infected cells and long lived productively infected cells, respectively. The factors e −θ 4 τ 4 and e −θ 5 τ 5 represent the loss of short lived productively infected cells and long lived productively infected cells during the intervals [t − τ 4 , t] and [t − τ 5 , t], respectively. Here, τ 1 , τ 2 , τ 3 , τ 4 , and τ 5 are positive constants.
The initial conditions of model (2.1)-(2.6) are
where C is the Banach space of continuous function mapping the interval [−τ, 0] into R 6 0 . By the standard theory of functional differential equations [31, 34] , we know that the system has a unique solution satisfying the initial conditions (2.7). Proposition 2.1. Let K(t, ϕ) be the solution of the model (2.1)-(2.6) with the initial conditions (2.7), then U(t), L(t), I(t), O(t), P(t), and C(t) are all non-negative and ultimately bounded for all t 0.
Proof. Assume that U(t) losses its positivity on some local existence interval [0, j] for some constant j and let j * ∈ [0, j] be such that U(j * ) = 0. By Eq. (2.1), we haveU(j * ) = ρ > 0. Hence U(t) > 0 for some t ∈ (j * , j * + κ), where κ > 0 is sufficiently small. This leads to contradiction and thus U(t) > 0, for all t 0. Furthermore, for all t ∈ [0, τ] we have
Thus, by a recursive argument, we get L(t), I(t), O(t), P(t), C(t) 0 for all t 0. Hence, R 6 0 is positively invariant for model (2.1)-(2.6). Next, from Eq. (2.1) we obtainU(t) ρ − γU(t). This implies that
are all non-negative, then lim t→∞ sup L(t) s 1 , lim sup t→∞ I(t) s 1 and lim sup t→∞ O(t) s 1 for all
The non-negativity of P(t) and C(t) implies lim t→∞ sup P(t) s 2 and lim t→∞ sup C(t) s 3 , where s 3 = 2εs 2 ξ .
The basic reproduction number for model (2.1)-(2.6) is defined as Proof. At any equilibrium EP(U, L, I, O, P, C) we have
From equations (2.8)-(2.13) we get an infection-free equilibrium EP 0 = (U 0 , 0, 0, 0, 0, 0), where U 0 = ρ γ and a unique endemic equilibrium EP 1 = (U 1 , L 1 ,
,
Therefore, if R 0 > 1, then c < 0 and P 1 > 0. Then the equilibrium EP 1 exists when R 0 > 1. Proof. Construct a Lyapunov function W 0 (U(t), L(t), I(t), O(t), P(t), C(t)) as:
Global stability of equilibria
Calculating dW 0 dt , we get
We have ξR 0 = hU 0 (ω 1 + ω 2 + ω 3 ), then
Then
Since R 0 < 1, then for all U(t), P(t), C(t) > 0 we have dW 0 dt 0. Moreover, dW 0 dt = 0 when U(t) = U 0 and
: dW 0 dt = 0 and N 0 be the largest invariant subset of D 0 . The trajectory of model (2.1)-(2.6) tend to N 0 [31] . All the elements of N 0 satisfy U(t) = U 0 and C(t) = 0. Then Eq. (2.6) yieldṡ
Also from Eq. (2.5) we get
The nonnegativity of I and O implies that I(t) = O(t) = 0 for all t. Then from Eq. (2.3), we have 0 =İ(t) = νL(t). It follows that, L(t) = 0 for all t. Hence,
Proof. Define W 11 (U(t), L(t), I(t), O(t), P(t), C(t)) as:
Note that from the equilibrium condition (2.13) that
Calculating dW 11 dt , we obtain
Define W 12 (U(t), L(t), I(t), O(t), P(t), C(t)) as:
Calculating dW 12 dt , we get
Define W 13 (U(t), L(t), I(t), P(t), P(t), C(t)) as:
Calculating dW 13 dt as:
Construct a Lyapunov function W 1 (U(t), L(t), I(t), O(t), P(t), C(t)) as
dt .
Now we have
From the equilibrium conditions, we have:
Utilizing the equilibrium conditions for EP 1 , we get
Simplifying the result, we obtain
We have
Note that ln
Then dW 1 dt will be
Then for all U(t), L(t), I(t), O(t), P(t), C(t) > 0 we have dW 1 dt 0. In addition,
Model with general infection rate
We generalize the model presented in the previous section by considering a more general incidence rate function Θ(U(t), P(t)) as:
2)
4)
We need the following assumptions on the function Θ(U, P) [18, 33, 49] .
(A1) Θ(U, P) is continuously differentiable, Θ(U, P) > 0, and Θ(0, P) = Θ(U, 0) = 0 for all U > 0 and P > 0.
(A2) ∂Θ(U, P) ∂U > 0, ∂Θ(U, P) ∂P > 0, and ∂Θ(U, 0) ∂P > 0 for all U > 0 and P > 0.
(A4) Θ(U, P) P is decreasing with respect to P for all P > 0.
This form of the incident rate Θ(U, P) with the above-mentioned Assumptions generalizes many popular forms like: bilinear incidence UP, saturated incidence UP/(1 + α 1 P), Beddington-DeAngelis incidence UP/(1 + α 1 P + α 2 U), and Crowley-Martin incidence UP/((1 + α 1 P)(1 + α 2 U)), where, α 1 and α 2 are nonnegative constants.
One can show that U(t), L(t), I(t), O(t), P(t) and C(t) are all nonnegative and ultimately bounded under initial conditions (2.7). 
Now, from Eqs. (3.9)-(3.10) and (3.14), we get 
Then, from Eqs. (3.7), (3.10), and (3.16), we get
Therefore, we can write U as U = Ψ(P). Note that Ψ(0) = ρ γ . From Eqs. 
then H(0) = 0. Let P be such that Ψ(P) = 0, i.e.,
Thus, the positive solution of Eq. (3.21) is given by
We can see from Assumption (A1) that
Moreover,
Assumption (A1) implies that ∂Θ(U 0 , 0) ∂U = 0, then
∂Θ(U 0 , 0) ∂P > 1, then H (0) > 0 and ∃P 1 ∈ (0, P) such that H(P 1 ) = 0. Let us define
which represents the basic infection reproduction number. Now, let P = P 1 in Eq. (3.7) and define g(U) = ρ − γU − (ω 1 + ω 2 + ω 1 )Θ(U, P 1 ) = 0. Then from Assumption (A1) we have g(0) = ρ > 0 and
is strictly decreasing function of U, and then there exists a unique U 1 ∈ (0, U 0 ) such that g(U 1 ) = 0. Moreover, from Eqs. (3.13) and (3.16)-(3.18), we have
Therefore, the endemic equilibrium EP G 1 = (U 1 , L 1 ,
Global stability of equilibria
The global stability analysis of the two equilibria of model (3.1)-(3.6) will be investigated in this subsection.
Proof. Construct a Lyapunov function Z 0 (U(t), L(t), I(t), O(t), P(t), C(t)) as Calculating dZ 0 dt as:
Using L'Hospital's Rule and simplifying the result, we get
From the Assumption (A4), we have
It implies that Proof. Define Z 11 (U(t), L(t), I(t), O(t), P(t), C(t)) as
Calculating dZ 11 dt as:
Define Z 12 (U(t), L(t), I(t), O(t), P(t), C(t)) as:
We calculate dZ 12 dt
Define Z 13 (U(t), L(t), I(t), O(t), P(t), C(t)) as
Calculating dZ 13 dt as:
Construct a Lyapunov function Z 1 (U(t), L(t), I(t), O(t), P(t), C(t)) as
It follows that
Utilizing these conditions for EP G 1 , we obtain
Simplifying the result, we obtain P(t) ) .
Note that
Then dZ 1 dt will be P(t) ) .
Simplifying the result, we get
In addition, from Assumptions (A1), (A2), and (A4), we have Θ(U(t), P(t)) P(t) − Θ(U(t), P 1 ) P 1 (Θ(U(t), P(t)) − Θ(U(t), P 1 ) 0, which gives Θ(U(t), P(t)) Θ(U(t), P 1 ) − P(t) P 1 1 − Θ(U(t), P 1 ) Θ(U(t), P(t)) 0.
Then we get that for all U(t), L(t), I(t), O(t), P(t), C(t) > 0 we have dZ 1 dt 0, moreover dZ 1 dt = 0 if and only if U(t) = U 1 , L(t) = L 1 , I(t) = I 1 , O(t) = O 1 , P(t) = P 1 and C(t) = C 1 . Applying L.I.P, we obtain that if R G 0 > 1, then EP G 1 is G.A.S.
Numerical simulations
In this section we perform numerical simulation for systems (2.1)-(2.6) and (3.1)-(3.6). We let τ = τ i , i = 1, 2, . . . , 5. In addition, we fix the values of parameters ρ = 10, γ = µ = 0.01, ζ = β = 0.3, ν = ε = 0.2, M 2 = 5, ξ = 6, Λ = 0.1, ρ = 0.4, ω k = 0.001, θ i = 0.6, i = 1, 2, . . . , 5 and k = 1, 2, 3 and the remaining parameters will be changed.
Numerical simulations for model (2.1)-(2.6)
In this subsection we conduct numerical simulations for model (2.1)-(2.6).
Stability of equilibria for different values of M 1
We choose three different initial conditions as: We take τ = ϑ = 0.01. Moreover, we consider two values of the parameter M 1 as:
(i) M 1 = 0.5, then we compute R 0 = 0.9387 < 1. Figure 1 shows that, for all IC1-IC3, the solution of the model tends to EP 0 = (1000, 0, 0, 0, 0, 0). It means that, EP 0 is G.A.S . (ii) M 1 = 10, then we compute R 0 = 3.1289 > 1. Figure 1 shows that the solutions of the model converge to the equilibrium EP 1 = (609.7, 2.587, 6.037, 12.94, 2.137, 13.62) for all IC1-IC3. Then, EP 1 is G.A.S. Figure 2 shows that as τ is increased, the concentrations of latently infected cells, short lived productively infected cells, long lived productively infected cells, HIV particles and B cells are decreased, while the concentration of uninfected CD4 + T cells is increased until they reach the equilibrium point EP 0 . Moreover, we have the following observations: Figure 3 shows that as ϑ is increased, the concentrations of latently infected cells, short lived productively infected cells, long lived productively infected cells and HIV particles are increased, while the concentrations of uninfected CD4 + T cells and B cells are decreased. We note that the parameter ϑ has no effect on the stability of equilibria. We conduct numerical simulations for model (3.1)-(3.6) with specific incidence rate function
where α 1 and α 2 are nonnegative parameters. We note that if α 1 = α 2 = 0, then we obtain bilinear incidence which are given in model (2.1)-(2.6), if α 1 = 0 and α 2 = 0, then we get saturated incidence, and if α 1 = 0 and α 2 = 0, then we obtain Holling type-II incidence. We can easily see that Θ(U, P) is continuously differentiable function. Moreover, Θ(U, P) satisfies Θ(U, P) > 0, and Θ(0, P) = Θ(U, 0) = 0 for all U(t) > 0 and P(t) > 0. Thus (A1) is satisfied. We have
for all U(t) > 0 and P(t) > 0. Moreover, ∂Θ(U, 0)
> 0 for all U(t) > 0, then (A2) is satisfied.
We also have d dU
Then (A3) is satisfied. Finally we have
Then (A4) is also satisfied. The basic reproduction number is given by
In this subsection, we fix ϑ = τ = 0.01, M 1 = 10 and choose α 1 and α 2 .
Effect of the saturation parameter α 1 on the HIV dynamics
In this case, we take α 2 = 0 then Θ(U, P) represents the saturation incidence. We choose the following condition: Figure 4 shows that as α 1 is increased, the concentration of the uninfected CD4 + T cells is increased, while the concentrations of latently infected cells, short lived productively infected cells, long lived productively infected cells, HIV particles, and B cells are decreased. We note that the parameter α 1 has no effect on the stability of equilibria. The reason is that R 0 does not depend on the parameter α 1 .
Effect of Holling type-II constant α 2 on HIV dynamics
For this case, we take α 1 = 0 then Θ(U, P) represents the Holling type-II incidence. Let us choose the following condition: U(s) = 700, L(s) = 2, I(s) = 2, O(s) = 4, P(s) = 1, C(s) = 10, s ∈ [−τ, 0]. We suggest different values of α 2 to see its effect on the solution of the model as we can see in Figure 5 . Moreover, we conclude the following results:
S, when α 2 > 0.0031. This means that α 2 can play the role of controller which can be designed to stabilize the system around the infection-free equilibrium EP G 0 .
Effect of antiviral treatment on the HIV dynamics
Let us introduce the HIV dynamics model under the effect of highly active antiretroviral therapies (HAART) as: 
where r ∈ [0, 1] is the efficacy of the reverse transcriptase inhibitor drug, while p ∈ [0, 1] is the efficacy of the protease inhibitor drug. If r = p = 0, then the HAART has no effect, if r = p = 1, the HIV growth is completely stopped. Let = r = p , consequently, the parameter R 0 ( ) is given by Since the goal is to clear the HIV from the body, then we have to determine the drug efficacies that make R 0 ( ) < 1 for model (4.1)-(4.6). Then
Since, 0 1, then for min < 1, EP G 0 is G.A.S, where min = max 0, 1 − 1 √ R 0 (0)
. We take α 2 = 0.0006, then, we find the following:
(i) if 0.2849 < 1, then R 0 ( ) < 1 and EP G 0 is G.A.S; (ii) if 0 < 0.2849, then R 0 ( ) > 1 and EP G 1 is G.A.S. We consider the following initial condition U(0) = 850, L(0) = 0.7, I(0) = 2, O(0) = 4, P(0) = 0.6, C(0) = 8 to show in Figure 6 the solution trajectories of model (4.1)-(4.6) for different values of . Clearly from the figure we can see that, the increasing of will increase the concentration of the uninfected CD4 + T cells and decrease the concentrations of latently infected cells, short lived productively infected cells, long lived productively infected cells, HIV particles, and B cells. 
Conclusion
In the literature, various mathematical models of virus dynamics have investigated the impairment of CTL functions. However, the dysfunction of B cell could happened during the HIV infection as it has been reported in several papers. In this work, we have studied HIV infection models with five delays including the impairment of B cell functions. We have taken into account three types of infected cells: short-lived productively infected cells (these cells live for short time and produce large amount of HIV particles), long-lived productively infected cells (which live for long time and produce small amount of HIV particles) and latently infected cells (such cells contain the HIV but are not producing it). Bilinear and general incidence rates have been considered in the first and second model, respectively. We have shown that, the solutions of the models are non-negative and ultimately bounded which ensure the wellposedness of the models. We have derived the basic reproduction number R 0 which fully determines the existence and stability of the two equilibria of the models. We have examined the global stability of the two equilibria of the models by using Lyapunov method and LaSalle's invariance principle. We have proven that (i) if R 0 < 1, then the infection-free equilibrium is G.A.S and the HIV is predicted to be completely cleared from the HIV infected individuals, (ii) if R 0 > 1, then the endemic equilibrium is G.A.S and a chronic HIV infection is attained. We have conducted numerical simulations and have shown that both the theoretical and numerical results are consistent. The results show that, when the B cells loss their functions during the HIV infection, the number of antibodies produced from the B cells are decreased and then the number of HIV particles are increased. Therefore, HAART is needed to improve the health of the HIV infected patient.
